Anna Danielyan: I’ll be enrolling in the ‘Clinical Development Strategies: Beyond Clinical Trials’ program at Harvard Medical School
Anna Danielyan, Medical Director at Ipsen, posted on LinkedIn:
“I’ve come to realize that education is my type of narcotic—the fuel that ignites my passion, drives my curiosity, and propels me forward on the journey of lifelong learning.
That’s why I’m thrilled to share that I’ll be embarking on a new learning adventure by enrolling in the ‘Clinical Development Strategies: Beyond Clinical Trials‘ program at Harvard Medical School.
I’m eager to explore innovative strategies, gain a holistic understanding of the drug development process, and refine my skills to make meaningful contributions to the field of healthcare. With a deep passion for advancing medical research and enhancing patient outcomes, I eagerly anticipate acquiring the new skills necessary to advocate for every patient.”
View the information attached to the post.
Source: Anna Danielyan/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”